Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals has filed a routine compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by MUFG Intime India Private Limited (the company's Registrar and Share Transfer Agent), confirms that securities received for dematerialization during Q4 FY2025-26 (January-March 2026) were properly processed and confirmed to depositories. Physical share certificates received for dematerialization were mutilated and cancelled after verification, and depository names were substituted in the register of members within prescribed timelines. This is a standard quarterly regulatory filing confirming proper handling of dematerialization requests.
This is a routine regulatory compliance filing with no material impact on the company's operations or stock price. It simply confirms that share dematerialization processes were handled correctly as per SEBI regulations during the quarter.